Panagora Asset Management Inc Adicet Bio, Inc. Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	SELL	$1.76 - $3.45 $50,255 - $98,511	-28,554 Reduced 55.18%	23,192 $54,000
Q4 2023 Feb 08, 2024	BUY	$1.11 - $1.89 $57,438 - $97,799	51,746 New	51,746 $97,000
Q2 2022 Aug 15, 2022	BUY	$10.26 - $20.81 $172,419 - $349,712	16,805 New	16,805 $245,000
Q3 2021 Nov 10, 2021	SELL	$6.29 - $9.93 $3,384 - $5,342	-538 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$9.19 - $15.93 $4,944 - $8,570	538 New	538 $6,000

59.2M

4.2K

6.7K

Ticker ACET
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,030,800
Market Cap $38.4M
Description
Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.